Gabrielle Martinique Thomas Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-329-0868 |
Hope Jones Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-329-0868 |
Kristina Norris, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-329-0868 |
Paris Strother Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-329-0868 |
Mrs. Tolisha C. Andrews, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-329-0868 Fax: 256-329-1101 |
Caitlin Carpenter, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-234-0592 Fax: 256-234-7014 |
Heather Hooper Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-329-0868 |
Katherine Motteler Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1784 Elkahatchee Rd, Alexander City, AL 35010 Phone: 256-329-0868 |
Catherine Kristina Williams Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3701 Dadeville Rd, Alexander City, AL 35010 Phone: 256-234-6366 |
News Archive
A new study in the Journal of the National Cancer Institute, published by Oxford University Press, indicates that high-quality cervical cancer screening can be done effectively using a completely automated approach. The researchers involved in the study indicate that automated technology could increase cervical screening coverage in underserved regions.
Viralytics Limited announced today that it has entered into a clinical trial collaboration agreement through subsidiaries of Merck & Co., Inc., Kenilworth, New Jersey, U.S.A. (known as MSD outside the United States and Canada) to evaluate the combination of Viralytics' investigational cancer immunotherapy CAVATAK, with MSD's KEYTRUDA, an anti-PD-1 (programmed death receptor-1) therapy.
People admitted to NHS hospitals with a cardiac arrest over the weekend do not face a higher risk of dying compared to those admitted during the week, according to new research presented today at the British Cardiovascular Society Conference in Manchester.
The Endocrine Society is calling for nominations for the third annual Award for Excellence in Science and Medical Journalism. The award recognizes outstanding reporting that enhances public understanding of health issues pertaining to the field of endocrinology.
Medtronic, Inc. today announced the initiation and first patient enrollment in a clinical study that will evaluate gaps in the implementation of evidence-based treatment guidelines among chronic heart failure patients post-hospital discharge.
› Verified 4 days ago